“Ozempic Santa.” Musk elaborated in a follow-up post he is technically using the Eli Lilly weight-loss drug Mounjaro over Novo Nordisk’s Ozempic, “but that doesn’t have the same ring to it.

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...

but Santa and Ozempic!” “Technically, Mounjaro, but that doesn’t have the same ring to it,” he clarified. Musk indicated that he prefers Mounjaro over Ozempic because he feels it has less ...

Elon Musk shared a photo dressed as Santa Claus, engaging social media users. He compared this look with a childhood Santa photo, receiving praise and humorous comments. The posts, shared on X ...

The launch of Mounjaro always raised the risk that it would cannibalise sales of Lilly's own GLP-1 agonist Trulicity (dulaglutide), which is competing head-to-head with Ozempic in the market ...

Like Ozempic, Mounjaro, the brand name for tirzepatide ... One user on X, in response to Musk's Christmas post: "Santa needs to put some meat on his bones." Musk had previously admitted to ...

which will help it meet what it anticipates will be rising demand for Mounjaro and other drugs in its incretin franchise, notably blockbuster GLP-1 agonist Trulicity (dulaglutide). "Expanding our ...

but Santa and Ozempic!” “Technically, Mounjaro, but that doesn’t have the same ring to it,” he clarified. Mounjaro, like Ozempic, belongs to a category of drugs known as GLP-1 inhibitors ...

but Santa and Ozempic!” “Technically, Mounjaro, but that doesn’t have the same ring to it,” he clarified. Mounjaro, like Ozempic, is a GLP-1 inhibitor – a class of drugs developed to ...

Roughly $15 billion of this total stems from just three drugs -- Mounjaro, Zepbound, and Trulicity. All of these are medications in Lilly's weight loss portfolio. However, another star performer ...